CHICAGO, July 24, 2022 /PRNewswire/ — At the 2022 AACC Annual Scientific Meeting and Clinical Laboratory Exposition, experts in laboratory medicine will present cutting-edge research and technology that are revolutionizing clinical testing and patient care. Of July 24-28 in chicago, the meeting’s more than 250 sessions will provide information on a wide range of current health care topics. Highlights include discussions exploring the use of artificial intelligence (AI) in personalized medicine, advances in multiplexed genomic imaging and sequencing, real-life applications of human brain organogenesis, how to build trust with patients and guide clinical decisions with mass spectrometry.
AI in Personalized Medicine. Precision medicine involves tailoring treatments to individual patients, and clinicians are increasingly using AI in their clinical prediction models to do this. In the opening speech of the meeting, Dr. Lucila Ohno Machadoassociate dean for health informatics and technology at the University of California San DiegoIt will present how AI models are developed, tested, and validated, as well as performance measures that can help clinicians select these models for routine use.
Imaging and multiplexed genomic sequencing. Thanks to advances in multiplexed genomic sequencing and imaging, we can identify small but crucial differences in DNA, RNA, proteins, and more. These techniques have also seen a 50 million-fold reduction in cost and comparable improvements in quality since they first emerged. Despite this, health care is just beginning to catch up with the implications of these technologies. dr george churchrecipient of the 2022 AACC Wallace H. Coulter Professorship Award and founding faculty member and director of the Wyss Institute for Synthetic Biology in Harvard Universitywill discuss the advances and implications of multiplex technologies in this plenary session.
Applications of Human Brain Organoid Technology. The human brain is a very complex biological system and is susceptible to several neurological and neurodegenerative disorders that affect millions of people around the world. In this plenary session, Dr. Alysson R. Muotri, professor of cellular and molecular medicine at the University of California San Diego School of Medicine, will explore the concept of human brain organogenesis, or how to recreate the human brain on a plate. Various applications of this technology in neurological care will be discussed.
Building Trust in Health Care. The world is having a crisis of trust that is affecting the delivery of healthcare around the world. dr Thomas Lee, medical director of Press Ganey Associates and professor of health policy and management at the Harvard TH Chan School of Public Health, will describe the importance of building trust between patients and health care workers in this plenary session. He will explore a three component model for building trust and the types of interventions that are most likely to be effective.
Clinical decision guide with mass spectrometry. In this, the closing speech of the meeting, Dr. Livia Schiavinato Eberlinassociate professor of surgery and director of translational research and innovations in Baylor College of Medicine, will analyze the development and application of direct mass spectrometry techniques used in clinical microbiology laboratories, clinical pathology laboratories and operating rooms. The presentation will focus on results from ongoing clinical studies employing two direct mass spectrometry techniques, electrospray desorption ionization mass spectrometry imaging, and MasSpec Pen technology.
Additionally, at the Clinical Lab Expo, more than 750 exhibitors will showcase innovative technologies that are just coming to market across all clinical laboratory disciplines.
“Laboratory medicine’s ability to adapt to changing healthcare circumstances and use scientific insights from the field to improve quality of life is unparalleled. This ability is constantly growing, with cutting-edge diagnostic technologies emerging every day in areas as diverse as mass spectrometry, artificial intelligence, genome sequencing and neurology,” said AACC Director General Mark J. golden. “The 2022 AACC Annual Scientific Meeting will shine a light on the pioneers in laboratory medicine who are mobilizing these new advances to improve patient care.”
session information
Registration for the AACC Annual Scientific Meeting is free for members of the media. Reporters can register online here: https://www.xpressreg.net/register/aacc0722/media/landing.asp
AI in Personalized Medicine
Session 11001 Biomedical informatics strategies to improve individualized predictive models
Sunday, July 24
5-6:30 pm Central US Time
Imaging and multiplexed genomic sequencing
Session 12001 Multiplexed and exponentially improving technologies
Monday, July 25
8:45 – 10:15 a.m. Central Time
Applications of Human Brain Organoid Technology
Session 13001 Applications of Human Brain Organoid Technology
Tuesday, July 26
8:45 – 10:15 a.m. Central Time
Building Trust in Health Care
Session 14001 Building Confidence in Times of Upheaval
Wednesday, July 27
8:45 – 10:15 a.m. Central Time
Guiding clinical decisions with mass spectrometry
Session 15001 Clinical Decision Guide with Molecular Information provided by Direct Mass Spectrometry Technologies
Thursday, July 28
8:45 – 10:15 a.m. Central Time
All sessions will take place in Room S100 of the McCormick Place Convention Center in chicago.
About the 2022 AACC Annual Scientific Meeting and Clinical Laboratory Exposition
The AACC Annual Scientific Meeting offers 5 days packed with opportunities to learn about exciting science from July 24-28. Plenary sessions will explore AI-based clinical prediction models, advances in multiplex technologies, organogenesis of the human brain, building trust between the public and healthcare experts, and direct mass spectrometry techniques.
At the AACC Clinical Lab Expo, more than 750 exhibitors will fill the exhibit floor of the McCormick Place Convention Center in chicago with displays of the latest diagnostic technology, including but not limited to COVID-19 testing, artificial intelligence, mobile health, molecular diagnostics, mass spectrometry, point of care, and automation.
About the AACC
Dedicated to achieving better health through laboratory medicine, the AACC brings together more than 70,000 clinical laboratory professionals, physicians, research scientists and business leaders from around the world focused on clinical chemistry, molecular diagnostics, spectrometry of mass, translational medicine, laboratory management and other areas of progress in laboratory science. Since 1948, AACC has worked to advance the common interests of the field, providing programs that promote scientific collaboration, knowledge, experience, and innovation. For more information visit www.aacc.org.
christine delong
AACC
Senior Manager, Communications and Public Relations
(f) 202.835.8722
[email protected]
molly pollen
AACC
Senior Director, Communications and Public Relations
(f) 202.420.7612
(c) 703.598.0472
[email protected]
View original content to download media:https://www.prnewswire.com/news-releases/artificial-intelligence-in-personalized-medicine-genomic-sequencing-advances-human-brain-organogenesis-building-trust-with-patients-guiding-patient-decisions- with-mass-spectrometry-and-much-more-to-explore-in-the-2022-aac-301592069.html
SOURCE AACC